What We’ve Funded

EveryCat-supported health studies have helped veterinarians improve the diagnosis and treatment of many diseases and conditions, changing the way feline medicine is practiced. Read about the grants we’ve funded below.

Search Our Past Grants

Name of Grant

Description

EC22-021: Comprehensive mutational profiling of the oncogenomic landscape of commonly-occurring cancers in domestic cats to pave the way for precision veterinary medicine and understanding cancer biology

Cancer is one of the leading causes of illness and death in cats, with the three most commonly occurring cancers

EC22-018: Characterization and causative investigation of Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia

Feline gastrointestinal eosinophilic sclerosing fibroplasia (FGESF) is a disease in cats, which is associated with masses in the gastrointestinal tract

EC22-015: Effect of EPA and DHA supplementation on renal function biomarkers and systolic blood pressure of proteinuric and borderline proteinuric cats diagnosed with chronic kidney disease

Chronic kidney disease (CKD) is the most common metabolic condition diagnosed in domestic cats. According to the International Renal Interest

EC22-007: EIDD-2801 (Molnupiravir): establishing an oral dose and evidence for efficacy in cats with FIP

Feline infectious peritonitis (FIP) is a highly fatal viral disease of cats with worldwide prevalence. Recently, several antiviral agents have

EC22-005: Acute phase protein and micro-RNA signatures for the diagnosis and prognosis of feline infectious peritonitis.

Feline Coronaviruses (FCoV) are found in the intestines of most pet cats, causing few problems. Unfortunately, in certain circumstances, they

EC22-004: Testing for Clopidogrel Resistance in Cats Presenting to First Opinion Practices

Cats with heart disease may form blood clots in the heart, which can travel to the hind legs and cut

EC22-003: Thromboelastography in cats with hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy (HCM), a disease in which the heart muscle becomes abnormally thick, is the most common form of acquired

EC22-002: Is platelet Toll-like receptor 4 the silent partner of thrombosis in cats with hypertrophic cardiomyopathy? Investigating the immunothrombotic interactions between histones and platelets

Hypertrophic cardiomyopathy (HCM) is a heart disease that affects 1 in 7 cats. Cats with HCM are at risk of

W21-064: Development of a questionnaire for the detection of cognitive decline in elderly cats

Cognitive dysfunction syndrome (CDS) is a disorder resulting in cognitive deficits in cats. Its diagnosis in elderly cats (i.e., 11+

W21-048: D-Dimer isolation and analysis of immunoreactivity in dogs, cats and horses

D-dimer is a by-product of clots formed in blood vessels. Measurement of D-dimer concentrations is used routinely in human medicine

W21-046: PPARαas metabolic target to restore intestinal permeability in an intestinal organoid model of feline diabetic enteropathy

Diabetes mellitus (DM) affects up to 70 cats per 10,000 in the U.S. DM is associated with defects in the

W21-042: Hormonal regulation of appetite in cats with and without chronic kidney disease

Maintaining good nutrition is a vital component in the overall care of cats with chronic kidney disease (CKD). Appetite is

W21-035: Creation of a Feline Living Bioarchive and Feline Induced Pluripotent Stem Cells for Use in Investigations into Feline Tooth Resorption & Other Feline Diseases

Cats commonly suffer from a dental disease called tooth resorption (TR). It is caused by odontoclasts; cells that are normally

W21-032: Glucagon-like peptide 2 in cats with inflammatory bowel disease

Inflammatory bowel disease (IBD) is the most common cause of long-standing vomiting and diarrhea in cats. Treatment options are limited,

W21-030: Intestinal S100/CALGRANULIN Expression in Cats With Chronic Enteropathy – Paving the Way For Novel Non-invasive Biomarkers and Pathway-specific Treatment Options

Chronic gastrointestinal inflammation in cats is a complex condition associated with an exaggerated immune re-sponse, but the exact cause of

W21-028: Comparison of Echocardiography and Biomarkers in Cats Eating High- or Low-Pulse Diets

Dilated cardiomyopathy (DCM) is a progressive and usually fatal disease in which the heart muscle becomes weak, leading to an

W21-018: Determining the clinical efficacy and safety of remdesivir for the treatment of naturally occurring feline infectious peritonitis

Feline infectious peritonitis (FIP) is a fatal coronaviral disease that affects cats around the world. Despite significant advances in research

W21-017: Use of a liposome-toll-like receptor complex (LTC) immune stimulant in the treatment of effusive FIP – A clinical trial

The main goal of this study is to determine the potential efficacy of a new immune stimulant (LTC) for treatment

W21-015: Effects of early life experiences on later problematic behaviors in rescued, fostered, shelter kittens

Behavior problems in cats decrease adoptions and increase returns and euthanasia in shelter cats. In owned cats, early separation from

W21-010: Development of a Rapid CRISPR CasRx Diagnostic Tool for Feline Infectious Peritonitis

Feline infectious peritonitis (FIP) is a devastating disease of cats that, up until recently, has been uniformly fatal. FIP occurs

Want to learn more about what we support?

View Our Past Research Grants

Make your own impact.

Support Cat Health Submit a Research Proposal